BVA Scottish Branch President Grace Webster said: "We commend the Scottish Government on seizing the opportunity to improve animal welfare through the introduction of a Bill to ban of the use of wild animals in travelling circuses. While the use of wild animals in travelling circuses may not affect a great number of individual animals, it is emblematic of the way we treat all animals and we would urge the rest of the UK to follow this precedent, introduced on ethical grounds.
"However, this package of measures seems a bit of a mixed bag. Until recently Scotland also led the way on dog welfare with a complete ban on tail docking, so we are extremely disappointed at the decision to reverse this stance. We have carefully considered all the evidence and remain convinced that tail docking in dogs, even specific breeds, is detrimental to their welfare. This is a retrograde step for animal welfare in Scotland, amidst an otherwise progressive package of animal welfare measures."
At the end of May, BVA Scottish Branch Junior Vice President Melissa Donald will be giving evidence to the Environment Committee in the Scottish Parliament ahead of a vote on whether or not to approve the change in law relating to tail docking.
Today’s announcement by the Cabinet Secretary for Environment, Climate Change and Land Reform Roseanna Cunningham MSP also included the introduction of controls to restrict the use of electronic training collars and a commitment to update regulations to combat the irresponsible breeding and sale of dogs, cats and rabbits.
Gudrun Ravetz, BVA President, added: "Animal welfare starts right at the beginning of a pet’s life, so the focus on pet licensing and breeding regulations is welcome. We know that a third of vets are seeing puppies they believe to have been illegally imported and an increasing number of owners are buying brachycephalic or designer breeds, like Scottish fold cats; pets must be purchased with owners prioritising animal health and welfare, rather than making an impulse buy based on looks alone.
"Yet we are saddened at the shortfall on legislation around aversive training aids for dogs, which we expect will still permit the use of training collars under expert guidance. We know using fear as a training tool is not only less effective than positive reinforcement, but can take its toll on a dog’s overall welfare. Without an outright ban, we have grave concerns over how enforceability will work. This raft of measures seems to give with one hand and take away with the other."
The Livestock Adviser of the Year Award recognises those who have made a real difference to the operations of livestock farmers.
Julian focuses on dairy cow health and his particular interests include nutrition and benchmarking herd performance. Amongst other things, he has helped one large Dorset dairy farm reduce its antibiotic usage by two thirds over an eight year period.
Julian said: "I was honoured to be named Livestock Adviser of the Year. This work is my passion – I love working together with farmers, getting involved in all aspects of herd management and thinking through different options to improve herd health and productivity."
Runners up for the award were Phil Baynes, Managing Director of Baynes Nutrition, and Ed Hill, veterinary surgeon at Thrums Veterinary Group.
Friars Moor, Baynes Nutrition and Thrums Veterinary Group are all members of the XLVets community of independent veterinary practices.
Alice Renner, Farm Marketing Executive of XLVets, said: "We were so pleased to hear of these awards going to such hard-working and deserving people. And it’s a great accolade for our members – reflecting how XLVets practices strive for clinical excellence and really get invested in the success of their clients."
Sileo provides a micro-dose of dexmedetomidine hydrochloride, a selective alpha-2 adrenoceptor agonist which Zoetis says helps a dog calm down or remain calm yet fully functional in situations involving fear-eliciting sounds.
Sileo is presented as an oromucosal gel formulation in a 3ml oral syringe that can be used to apply multiple doses.
Zoetis says that its user-friendly application means that, once prescribed, it can be given by the dog owner and used only when needed for each noise anxiety event. It takes effect within 15 - 60 minutes and last for 2-3 hours. Should the fear-eliciting noise continue, further doses can be given at two hour intervals up to a total of five times during each noise event.
The company says that even when the full dosing limit is used, the dog will remain functional during treatment; the clinical effects of dexmedetomidine are dose-dependent and the anxiolytic effect is reached before the sedative effect.
Animal behaviourist, Jon Bowen BVetMed DipAS (CABC) MRCVS, said: "Fear of seasonal loud noises such as fireworks, thunder and gunshots are known to affect around 50% of the UK dog population but the prevalence of fears of other everyday noises and the extent to which those fears contribute to nuisance and problem behaviour in dogs is something we are researching at the moment. Sileo is ideal as an acute anxiolytic for planned or expected events such as fireworks or thunder, but it has an even wider range of potential applications in planned events that involve stressful noise exposure including travel, social gatherings and even visits to the vet."
Sileo is available to order now via your veterinary wholesaler.
For more information contact your Zoetis account manager or customer support on 0854 300 8034 or visit www.zoetis.co.uk/Sileo.
New subject areas include emergency planning, traffic accidents, excessive bleeding, seizures, poisonings, choking and breathing problems, caesareans, GDV and abdominal emergencies, and pain assessment and management.
ECC is the first element of the new Practical and Clinical Skills section of the BSAVA’s online Professional Development Phase (PDP) Resource Bank, and takes the total to more than 100 hours of free online CPD support matched directly to the RCVS PDP competences.
The BSAVA PDP resource bank is designed to help veterinary surgeons to enhance practice expertise, develop their practices’ professional and business skills, and advance an ethos of reflective learning and continuous professional development (CPD) alongside veterinary expertise.
Members can pick and choose the most appropriate content for their professional development from more than 250 resources in multiple formats to suit a range of learning preferences, including short ‘how to’ videos, webinars written by and featuring veterinary specialists, podcasts, documents and interactive PDFs and web links.
BSAVA President John Chitty said: "BSAVA continues to lead the way in CPD learning resources and this easily accessible and flexible PDP Resource Bank has proven very popular in helping members to meet the challenges of delivering 21st century veterinary medicine."
The BSAVA PDP Resource Bank content is reviewed by committee and there will be ongoing development of new resources – including employer specific resources for practices supporting new graduates.
For more information visit www.bsava.com/pdp
Ceva says the aim of the course is to enable vets to get the most out of their ocular exams and gain confidence in identifying ocular lesions associated with feline hypertension.
The course is presented by Dr Ben Blacklock BVSc (Hons), Dipl. ECVO, MRCVS, senior lecturer in veterinary ophthalmology at the University of Edinburgh.
It comprises of 10 short videos grouped into four sessions, along with a self-assessment quiz to consolidate learning for each module.
The course counts for a total of two hours’ CPD.
Course content includes: the patient/equipment set up and getting the most from an ophthalmoscope; determining what is normal and what is abnormal during ocular examinations; an overview of ocular pathologies associated with hypertension; avoiding common pitfalls and mistakes; and hints and tips on how to take photographs of the fundus on a mobile phone.
To register, visit www.veterinarywebinars.com/community/ceva.
The new presentation is honey-flavoured and is available in 30ml or 100ml bottles with a syringe for precise dosing.
It has a two-year shelf life and a broached shelf life of six months.
Dechra companion animal brand manager, Thomas Johnson, said: “The addition of Felimazole Oral to our product range will provide vets with the flexibility to prescribe Felimazole as either a tablet or oral solution to accommodate the preferences of both the cat and its owner.
"This, combined with our extensive endocrinology resources, will ensure that vets have all the necessary tools to support their feline hyperthyroid cases.”
https://www.dechra.co.uk/cushings-connect
https://www.dechra.co.uk/addisons-connect
https://www.dechra.co.uk/search?q=felimazole#/search=Felimazole
https://apps.apple.com/gb/app/dechra-endocrinology-app/id1660737534
BCF has announced the launch of the Vita CR x-ray system from Carestream (formerly known as Kodak).
According to the company, the system provides high quality x-ray images, seamless integration into your existing workflow and improved productivity.
BCF says the Vita is ideal for practices looking for an affordable move from chemical to digital radiographic processing and offers:
Elly Pittaway, Veterinary Surgeon and Director at Broadlane Vets in Coventry said: "The Vita produces excellent quality images, is small, compact and really easy to use. It has changed things dramatically, especially for the nurses who no longer have to use nasty chemicals with wet processing. The vets find it easy to take x-rays so are encouraged to take more as it no longer takes the time it used to."
Kimberly Palgrave, the new in-house vet at BCF said: "At BCF, we understand that the ability to take high-quality x-rays quickly and accurately improves both clinical diagnostics and practice workflow. With the Vita x-ray system you can forget about the cost of purchasing and storing film and chemicals as well as health and safety issues associated with the handling and disposal of processor chemicals.
"Using the latest technology that the Vita offers you will reduce not only the number of repeated x-rays taken due to poor radiographic technique or processing faults, but also time spent performing routine equipment maintenance. This results in improved efficiency of your staff, saving you time and money. Faster image production may also enable a shorter duration of anaesthetic/ sedation to be used, improving patient care."
For more information, visit www.bcftechnology.com or ring BCF on 01506 460023.
Bayer Animal Health has launched a new version of Drontal which is presented as a bone-shaped tablet.
The company says that this is the UK's first worming tablet shaped like a bone, and that the product is designed to help improve client compliance.
Dan White, Group Product Manager at Bayer Animal Health said: "Almost half of dog owners - surveyed prior to launch - indicated that new Drontal bone would encourage them to worm their dogs more routinely. This is clearly great news for practices especially during these difficult economic times.
The launch of Drontal bone will be supported by a marketing drive that includes a new advertising creative concept which will be featured as part of a national TV advertising campaign, and an online consumer-facing competition called Give Your Dog A Bone designed to engage further with dog owners and communicate the benefits of having a worm-free dog.
Dan added: "The online and supporting consumer PR campaign will bring to life the special bond between pet and owner, and celebrate the happiness that dogs bring to our lives when they are happy, healthy and worm-free."
Practices can request a practice support pack to promote the availability of Drontal bone which will include a notice board picture-pack aimed at dog owning clients by calling their Bayer Territory Manager or 01635 563380.
The Give Your Dog a Bone competition and PR campaign has been devised by leading healthcare communications agency Pegasus. The new 'bone-shaped' TV and print creative has been developed by the recently-appointed advertising agency Dinosaur and will launch in early 2012.
Drontal's Give Your Dog a Bone competition will be launched on 1st March 2012 at www.giveyourdogabone.co.uk.
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
References
Researchers and practitioners working in any field of academia, industry and/or clinical practice are invited to apply for an award of up to £2,000 to fund a research project relevant to the aims of the VMG, which represents veterinary professionals working in leadership and management roles.
The VMG says it has launched the scheme to help veterinary leaders embrace the challenges and opportunities faced by the sector and to help them to continue to meet patient needs effectively while remaining profitable.
VMG Junior Vice President Mr Richard Casey said: "Business landscapes are changing and the veterinary world is no exception. The VMG is ideally placed not only to support our members but also to help the wider profession. We hope that our grant scheme will support research that enhances our understanding of contemporary veterinary business, leadership and management and helps us to develop a solid evidence base for best practice. We are looking forward to receiving some exciting proposals."
Further information, including the Stage 1 application form and guidance notes, are available here: https://www.vetmg.com/vmg-research-awards/
The deadline for applications is 19 July 2019.
The College has confirmed that it has now received an official complaint about the matter and it is now investigating under its normal 'concerns' investigation process.
Professor Argyle made a private statement about the allegations to RCVS Council at its meeting today, having already answered written questions from a number of Council members in the preceding days.
The Council did not ask Professor Argyle to step aside, but acknowledged that this was his choice, made for personal reasons.
The College said that in line with its normal protocols, and to ensure fairness for all parties, it will not make any further public comment about the investigation for the time being. However, it wanted to stress that it remains firmly committed to following due and proper process in all its regulatory activities.
The booklet contains practical advice on handling rabbits, anaesthetic drugs, procedures and what to look out for from the moment the rabbit arrives into the practice up to recovery and homecare. Special attention is given to reducing anxiety in rabbit patients as much as possible at every stage.
Topics covered in the booklet include: medications in rabbits generally used according to the UK prescribing cascade, preparing for rabbit anaesthesia in clinic, staff training, an overview of anaesthetic drugs, the induction process and important points of difference, monitoring and recovery and adjunctive treatments.
Richard Beckwith, country manager of Jurox said: "Rabbits are prey species and often become stressed in the veterinary practice environment which can have a negative impact during anaesthesia and post-anaesthesia. Our new Considerations for Anaesthetising Rabbits expert panel guidelines booklet will help address this and raise anaesthesia and analgesia standards in veterinary practices."
For more information, visit www.alfaxan.co.uk, contact Jurox customer services on info@jurox.co.uk or telephone 0800 500 3871.
Overall, there has been a 17% decline in Kennel Club registrations of all dogs so far this year.
However, new registrations of Pugs, French Bulldogs and English Bulldogs have declined by 42%, 39% and 34% respectively, putting these three breeds into the list of 'top five fallers' this year.
The Brachycephalic Working Group (BWG), which is made up of vets, national animal welfare organisations, scientists, and dog breed clubs has welcomed the news.
Dan O’Neill, Chair of the BWG said: “The drop in puppy registrations for these flat-faced breeds is a welcome step in the right direction, although these should be seen with some caution.
“We hope this is a sign that more and more puppy buyers, owners and breeders are considering the serious health and welfare implications for flat-faced dogs.
ukbwg.org.uk
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
The study, which was led by Robert Hyde MRCVS from the School of Veterinary Medicine and Science at the University of Nottingham, aims to create an automated diagnostic support tool for the diagnosis of herd level mastitis origin, an essential first step of the AHDB mastitis control plan.
Mastitis data from 1,000 herds’ was inputted for several three-month periods. Machine learning algorithms were used to classify herd mastitis origin and compared with expert diagnosis by a specialist vet.
The machine learning algorithms were able to achieve a classification accuracy of 98% for environmental vs contagious mastitis, and 78% accuracy was achieved for the classification of lactation vs dry period environmental mastitis when compared with expert veterinary diagnosis.
Robert said: “Mastitis is a huge problem for dairy farmers, both economically and in welfare terms. In our study we have shown that machine learning algorithms can accurately diagnose the origin of this condition on dairy farms. A diagnostic tool of this kind has great potential in the industry to tackle this condition and to assist veterinary clinicians in making a rapid diagnosis of mastitis origin at herd level in order to promptly implement control measures for an extremely damaging disease in terms of animal health, productivity, welfare and antimicrobial use."
Reference
All vets are encouraged to take part, and everyone who does will get a copy of the results.
The survey covers small animal, large animal and equine in all aspects of preventative health care and surgery.
It also looks at repeat prescription charges, the routine use of analgesia and antibiotics in neutering and lab interpretation fees, comparing them to last year.
https://surveys.spvs.org.uk
As part of the partnership between the two companies, anyone who takes part in one of Improve's CPD courses in 2018 will be entitled to 6 months' half-price pet insurance from Agria.
Online Bitesize CPD modules cover topics including: cardiology, ophthalmology, small animal medicine, feline medicine and exotic animals. Modules are 20, 40 or 60 minutes in length and provide veterinary professionals with interactive experiences which count toward annual CPD requirements in short convenient bursts, earning digital badges and certificates to demonstrate total CPD achieved.
Nick White, Head of Veterinary Channel at Agria, said: "We’re delighted that our partnership with Improve International will give veterinary professionals free, instant access to high-quality and engaging CPD. Not only are the modules available varied and highly relevant, the 'bitesize' nature of the training makes it extremely convenient for busy practice staff to access.
"This is a great incentive for any practices not yet working with Agria to get onboard. As well as benefitting from free CPD, practices will also be working with a specialist lifetime insurer offering 5 weeks free insurance policies and much more for clients and their pets."
For more information, contact your Agria Business Development Manager or visit: www.agriapet.co.uk/bitesize and complete the Contact Us section, using 'FREE CPD' in the subject line of the enquiry box.
The course is aimed at veterinary professionals across Europe who want to advance their knowledge and diagnostic skills, progress their academic qualifications and gain recognition in their field.
The GPAdvCert in Small Animal Medicine is for veterinary surgeons who have already completed a General Practitioner Certificate in Small Animal Medicine (GPCertSAM) or a Postgraduate Certificate (PgC) in Small Animal Medicine.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme will be delivered in three, five-day blocks of training by globally recognised experts in three European training centres - Sheffield, UK; Porto, Portugal and Berlin, Germany. The programme includes a practical session in which delegates will perform an upper and lower gastrointestinal endoscopy under the guidance of their tutor.
David Babington MRCVS, Business Development Director of Improve International (pictured right), said: "Delegates attending our first GPAdvCert in Small Animal Medicine will enhance their skills and confidence in dealing with complex animal medicine cases. Each module will take their knowledge beyond Postgraduate Certificate level with more in-depth and advanced content covering topics as diverse as mycobacterial and ureteric disease. They will also learn how to design a detailed diagnostic plan and build an understanding of nuances in interpreting laboratory findings to enable them to manage cases requiring complex therapeutic management with confidence."
He added: "The qualification is a natural ‘next-step’ for veterinary surgeons wanting to further progress their knowledge of small animal internal medicine. It will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice and will also provide them with skills which they can pass onto their team."
Improve says the successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Medicine (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
Certified B Corps are companies that meet exceptionally high standards of social and environmental performance, transparency and accountability.
The process examines a company’s full range of processes, from supply chain to charitable giving and employee benefits.
Other well-known names that have achieved B Corp status include Patagonia, The Body Shop, BrewDog, TOMS, Ben and Jerry’s and Innocent Drinks.
Dr Caroline Collins, from Pennard Vets, said: “We’re extremely proud to achieve B Corp status and there’s no doubt that it will be transformational for the business, in the same way that becoming an employment ownership trust has been.
"Being employee owned and socially minded is a huge draw for vets and nurses seeking a change in their career, who want to be part of an organisation where they can have a real say in the running of the practice and make a tangible difference to the environment.
“It also means that we can now make very long-term decisions, that could even take several decades to pay off, which would be very difficult to do in a traditional shareholder business, and that gives our team the authority to always do the right thing.”
Vetoquinol UK has launched Dolpac®, its new wormer for dogs.
Dolpac® is a broad spectrum anthelmintic for dogs containing pyrantel, oxantel and praziquantel. Individually these ingredients are effective against individual worm species and the combination of all three provides specific activities against the most common roundworm and tapeworm species.
According to the company, clinical studies carried out in accordance with internationally recognised guidelines have shown that Dolpac® provides an excellent ability to reduce parasitic infection.
“Dolpac® offers vets and their clients an easy to use worming alternative at an affordable price,” explains Mark Leddy, Vetoquinol’s Marketing Department Manager. “Our aim is to help to increase the number of dog owners worming their pets at the correct frequency, which will not only protect their dogs, but their children as well. We have introduced a number of features to help achieve this objective, there are three tablet sizes to cover all weight ranges and the tablets are flavoured and easy to give, and there are dispensing envelopes in every pack. We also provide a dosing wall chart and a client worming guide.”
For more information, contact your Vetoquinol representative or visit the Dolpac website, http://www.dolpac.co.uk/, which offers information for both vets and clients.
Vethelpdirect.com, the website founded by VetSurgeon.org member, Susie Samuel MRCVS, has launched a new system called VetReviews which allows your clients publish a review of your service directly from your own website.
To use the system, you (or perhaps more likely your website person) embed a small form on your website, called a widget, as shown on this example: www.baytreevets.co.uk (bottom right hand side).
Clients then click the link in the widget to submit a review of your practice, or to read existing reviews.
To ensure fair play, each review is checked by a person who removes any spammy or malicious reviews, and looks for any signs of fraudulent multiple reviews being submitted by one person.
In the event of a negative review, the practice is given 5 days to respond before the review is published, which means the review isn't displayed without the practice's side of the story.
However, as Susie points out, a single negative review is not necessarily a bad thing; most people are able to put one bad review into context. Indeed, a small number of negative, or less positive reviews tends to make the glowing ones seem more credible.
VetReviews are optimised for inclusion in Google search results, which should also help your search engine visibility.
For more information about VetReviews (which is a free upgrade for existing customers), email: vets@vethelpdirect.com, or telephone 0845 4961 204.
The RCVS has announced that it will start to accept the first applications for the new Advanced Practitioner status from the start of September.
The new accreditation status represents a 'middle tier' between veterinary surgeons holding an initial veterinary degree and RCVS Specialists and will demonstrate that the veterinary surgeon has advanced knowledge and experience in a designated field of veterinary practice.
Practising veterinary surgeons with at least five years' experience and a relevant postgraduate qualification are eligible to apply to be recognised as RCVS Advanced Practitioners. Accepted qualifications include the Certificate in Advanced Veterinary Practice (CertAVP) with a designation; the RCVS Certificate awarded up to 2012; postgraduate clinical qualifications awarded by universities or recognised awarding bodies; and other relevant clinical postgraduate master's degrees. Full details of eligible qualifications can be found at www.rcvs.org.uk/advanced
Advanced Practitioners will be expected to undertake at least 250 hours of continuing professional development (CPD) over each five-year period of accreditation, of which 125 hours should be in their designated field.
Dr Kit Sturgess is Chair of the Advanced Practitioner Assessors Panel and was involved in the development of the scheme. He said: "I am very proud that we will soon be accepting applications for the Advanced Practitioner status, just two years after the need for such an accreditation was highlighted by Professor Sir Kenneth Calman's Specialisation Working Party, set up to look at the whole specialisation framework.
"Being an Advanced Practitioner is more than just a status - it will demonstrate to members of the public and colleagues alike that a veterinary surgeon is working at an advanced level in their field and has made an ongoing commitment to career development and lifelong learning through engaging with CPD over and above the RCVS minimum requirement."
Applications from holders of the RCVS Certificate in Advanced Veterinary Practice (CertAVP) with a designation can apply from 1 September 2014 while those holding any other relevant qualifications can apply from 13 October 2014. The deadline for all applications during this first round is 30 November 2014.
Applications can be made online at www.rcvs.org.uk/advanced where further information about eligible qualifications, CPD requirements and other details can be found. The application fee for this year is £50 - from next year it will be £80. Thereafter there will be an annual fee to remain on the list (£80 by direct debit; £90 otherwise, at current rates).
All eligible applications will be assessed by the Advanced Practitioner Assessors Panel. The first list of Advanced Practitioners is due to be published, alongside the updated Specialist list, in spring 2015 subject to approval by the RCVS Education Committee in February 2015.
If accepted on to the list, practitioners will be able to use 'RCVS Advanced Practitioner in [designated field]' after their names. The accreditation and its designation will also be a primary search field on the RCVS Find a Vet practice database as well as appearing after an individual's name on the Check the Register search tool.
Once the first list has been published, the status of Advanced Practitioner will be promoted to the public.
A free webinar about Advanced Practitioner status, hosted by the Webinar Vet, will take place on Tuesday 30 September at 8.30pm. To register for the webinar visit www.thewebinarvet.com/rcvs-advanced-practitioner-status
For further advice or details about making an application for Advanced Practitioner accreditation, visit www.rcvs.org.uk/advanced or contact the Education Department on 020 7202 0791 or ap@rcvs.org.uk
The RCVS Disciplinary Committee has reprimanded Gloucestershire veterinary surgeon Adele Lewis for failing to pass on information about a horse’s clinical history to a potential buyer during a pre-purchase examination.
Ms Lewis, the sole principal of the Cotswold Equine Clinic in Lechlade, Gloucestershire, carried out the examination of a pony called Luke on 13 February 2014. Luke was owned by Mrs Booth who was a long-established client of Ms Lewis, both at her previous practice, Bourton Vale, and at her current practice. The examination was carried out on behalf of the prospective purchaser, Mrs Grieve.
Upon examination Ms Lewis certified that, in her opinion, Luke’s veterinary history did not increase the risk of purchase.
Following the purchase of Luke, Mrs Grieve attempted to obtain insurance for Luke and found out from a pet insurance company that a claim had been made by Mrs Booth in September 2013. She subsequently found out that, following concerns expressed by Mrs Booth and her trainer about Luke’s movement and their wanting an expert opinion, Ms Lewis had referred him to Dr Kold, a Specialist in Equine Orthopaedics, in September 2013. Dr Kold had diagnosed Luke with lameness and had given him intra-articular medication. Luke had also had a follow-up appointment with Dr Kold about four weeks later in October 2013.
The Disciplinary Committee hearing commenced on Tuesday 13 October 2015. At the outset, Ms Lewis admitted several parts of the charges (charge A and charge B) against her. In regards to charge A, she admitted that she had failed to inform Mrs Grieve that, when she examined Luke on 24 September 2013, his then owner Mrs Booth had complained firstly that Luke was “not tracking up and going forward” and, secondly, that he had improved significantly when put on a Phenylbutazone trial. She also admitted that she had referred him to Dr Kold for a poor performance investigation and that she ought to have informed Mrs Grieve of these matters.
In regards to charge B, she admitted that she completed a Certificate of Veterinary Examination in which she had declared that Luke’s veterinary history did not increase the risk of purchase and allowed the vendor’s declaration to include assertions that there had been no previous lameness and no intra-articular medication given in the last 12 months. Ms Lewis admitted that she ought to have known that her declaration that Luke’s veterinary history did not increase the risk of purchase was incorrect.
However, Ms Lewis denied being aware that Dr Kold had diagnosed lameness, administered an intra-articular corticosteroid to Luke and examined and noted a problem with his breathing, including upper airway disease and possible lower airway disease. Furthermore, she denied dishonesty in regards to both the charges against her and in relation to vendor declarations made on the Certificate of Veterinary Examination regarding previous lameness and intra-articular medication.
During the course of the hearing, Ms Lewis told the Committee that she had not received the reports about the two consultations by Dr Kold (despite their having been sent to her by letter and, with respect to the second report, also by email) and that she was therefore unaware of his findings when she carried out the pre-purchase examination. She also stated that she had not been informed of these by Mrs Booth. During her evidence, Ms Lewis also admitted having entered inaccurate information on a veterinary report to assist with an insurance claim.
The Committee did not find Ms Lewis to be an impressive witness citing the fact that her “explanations as to her practice showed a worrying absence of probity in the completion of veterinary reports for the purposes of insurance claims, and an absence of any effective practice management, consistent with acceptable practice.”
However, the Committee felt it did not have the evidence to conclude that Ms Lewis had acted dishonestly during the pre-purchase examination. It cited the fact that her actions, when informed by the purchaser Mrs Grieve of Dr Kold’s examination, did not appear to be those of someone trying to cover their tracks.
In regards to charge A, the Committee also found that the “apparently chaotic manner in which Ms Lewis ran her practice, and her own opinion that the pony was sound, would appear to have led her to wrongly disregard these matters from disclosure.”
In making its decision on her conduct and sanction, the Committee said that Ms Lewis’ failure to fully communicate to Mrs Grieve all the relevant information about Luke’s veterinary history fell far short of the conduct expected from a veterinary surgeon. It also cited the utmost importance of a complete and accurate certification process, as made clear in the RCVS Code of Professional Conduct and the Twelve Principles of Certification.
Chitra Karve, chairing the Committee and speaking on its behalf, said: “The Committee continues to emphasise the importance of maintaining the integrity of veterinary certification in any aspect of practice. Mrs Grieve told this Committee that if she had been fully informed about Luke’s veterinary history she would not have purchased the pony. It is clear from the evidence that it affected Mrs Grieve’s ability to insure the pony. Ms Lewis has accepted that the information about Luke’s veterinary history, not having been disclosed, was capable of affecting the risk of purchase. The public are entitled to rely upon veterinary surgeons providing complete and accurate information, when certificates and reports are prepared.”
In mitigation, the Committee paid regard to Ms Lewis’ inexperience at running her own practice and found no issue with her competence or clinical ability as a veterinary surgeon. It concluded that she had acted out of character and that there was no financial motivation for her actions. It also found it “highly relevant that the facts admitted and found proved related to a single pre-purchase examination.”
It also noted that Ms Lewis has now put in place a practice management system and has shown insight into her actions, by taking active steps to better comply with her obligations under the Code of Professional Conduct. She had also made early admissions of guilt and made a full apology to both Mrs Grieve and the RCVS both at the outset of the hearing, and in her evidence.
Chitra Karve added: “Having had the opportunity of observing her demeanour at this hearing, the Committee believes that it is unlikely that she will repeat her conduct.... The Committee has concluded that an appropriate and proportionate response in this case is to reprimand Ms Lewis.”
Vetoquinol has just launched its Marbocyl 10% online case study competition in which veterinary surgeons are being invited to provide information about how they treat E.coli mastitis. Two winners (one in the UK and one in Ireland) will win a BCF EASI-SCAN cattle ultrasound scanner with goggles worth over £6000.
Vetoquinol's large animal product manager, Susan Mitchell said: "We hope that this case study competition will help us gather further information on how E.coli mastitis is treated by veterinary surgeons in the UK and Ireland. I would encourage large animal veterinary surgeons to be part of this UK and Irish survey to highlight the severity of the disease and share their success stories."
The competition will run until the end of October 2011.
For your chance to win a BCF EASI-SCAN and goggles visit http://www.vetoquinol.co.uk/.
The RCVS Disciplinary Committee has dismissed a case against a Kent veterinary surgeon convicted of tail-docking and also charged with misleadingly altering an owner's record relating to tail dockings.
At the outset of the four-day hearing, David Smith, of Lakeview Veterinary Centre, Deal, admitted he had been convicted of an offence of tail docking on 14 December 2010 at the Channel Magistrates Court.
He said that, in 2008, he had misinterpreted the legislation about tail docking and as a result had removed the tails of a litter of 13 Rottweiler puppies. He was subsequently convicted of illegal docking.
Mr Smith also accepted he had altered the owner's record, at the owner's request, when the RSPCA was investigating the circumstances of the docking by adding the words "for law enforcement", but maintained this alteration was to clarify the record to which he had initially added the words "for security selection"; he denied any attempt to mislead, or that he ought to have known it may mislead.
The Committee accepted that Mr Smith misinterpreted the legislation and had taken some steps to satisfy himself that the tail docking was legal, namely: he had asked an employee colleague to make enquires of the College and, as advised, he had downloaded a copy of the AWA 2006 to read and to make his own decision with regard to legality; some enquiry had been made by the practice of the Department for Environment, Food and Rural Affairs (Defra) at Reigate; and, Mr Smith had himself researched dog breeds on the Kennel Club website.
The Committee also accepted that he had asked and been told that the client had previously supplied dogs to the police.
However, the Committee found that these steps were inadequate; in particular, he should have contacted the College and Defra himself and not delegated this to administrative staff. Furthermore, that he should have obtained confirmation of the advice given in writing.
Regarding the alteration of the owner's record, the Committee was satisfied that this annotation was added for clarification. The Committee was not satisfied that the addition 'for law enforcement' altered the meaning of what was already stated on this form, and found the wording confirmed Mr Smith's misapprehension at the time of the legality of the tail docking.
This charge, which alleged that the alteration had been carried out misleadingly, was dismissed.
The Committee also said that Mr Smith's reluctance to engage with the police and the RSPCA during their later investigation had been regrettable: as a professional he had had a duty to co-operate fully. However, it concluded that this had been "of little probative significance".
The Committee would like to make it clear that it is the responsibility of every practising veterinary surgeon to ensure that tail docking is legal in each and every instance before carrying out the procedure. If there is any doubt, then tail docking should not take place.
In deciding whether Mr Smith was fit to practise, the Committee took into account two previous RCVS Disciplinary Committee findings involving tail-docking.
It concluded these were significantly different. In the first case, the respondent knew that the tail docking he had carried out was illegal. On the contrary Mr Smith had misguidedly believed the docking he carried out was permitted.
In the second case there had been several charges, in addition to the charge of tail docking. In this case no charges other than those related to tail docking had been alleged against Mr Smith.
It further noted that no issues of clinical competence were raised, and that the dockings were undertaken less than 12 months after the new legislation came into force.
Speaking on behalf of the Committee, Vice-Chairman Beverley Cottrell, who chaired the hearing, said: "The Committee has expressed its disapproval about Mr Smith's failure to make adequate investigations of the College and of Defra, and his erroneous interpretation of the Act.
"In reaching its decision, the Committee has paid particular attention to issues of animal welfare, maintaining public confidence in the profession and the upholding of proper standards of conduct.
It has concluded that Mr Smith's conduct fell short of that to be expected of a veterinary surgeon but does not consider that it fell far short."
After directing that the case should be dismissed, Mrs Cottrell added: "The Committee would like to make it clear that it is the responsibility of every practising veterinary surgeon to ensure that tail docking is legal in each and every instance before carrying out the procedure. If there is any doubt, then tail docking should not take place."